Treatment of Brugada Syndrome After Aborted Cardiac Arrest or Documented Sustained Ventricular Tachycardia
Clinical scenario
This protocol applies to patients with Brugada syndrome who have survived an aborted cardiac arrest, or who have documented spontaneous sustained ventricular tachycardia — the highest-risk presentations of this condition.
Treatment approach
Management centres on a device-based intervention as the primary strategy. For patients who are eligible for the primary approach but face a contraindication or decline it, an antiarrhythmic pharmacological alternative is included in the protocol.
Full treatment selection criteria and the complete protocol are available via the link below.
References
DOI: 10.1093/eurheartj/ehac262
- ICD implantation is recommended in patients with BrS who: (a) Are survivors of an aborted CA and/or (b) Have documented spontaneous sustained VT.
- Quinidine should be considered in patients with BrS who qualify for an ICD but have a contraindication, decline, or have recurrent ICD shocks.
View source ↗